Literature DB >> 9609386

The glutathione dependence of inorganic sulfate formation from L- or D-cysteine in isolated rat hepatocytes.

J Huang1, S Khan, P J O'Brien.   

Abstract

The GSH dependence of the metabolic pathways involved in the conversion of cysteine to sulfate in intact cells has been investigated. It was found that hepatocyte-catalysed sulfate formation from added L-cysteine did not occur if hepatocyte GSH was depleted beforehand, but was restored when GSH levels recovered. Furthermore, sulfate formation did not recover in GSH-depleted hepatocytes if GSH synthesis was prevented with buthionine sulfoximine. Thiosulfate formation was, however, markedly enhanced in GSH-depleted hepatocytes. These results suggest that thiosulfate is an intermediate in the formation of inorganic sulfate from L-cysteine and that GSH was required for the conversion of thiosulfate to inorganic sulfate. Much less sulfate was formed if the cysteine was replaced with cysteinesulfinate. Furthermore, sulfate formation from L-cysteine was markedly inhibited by the addition of the transaminase inhibitor DL-cycloserine or the gamma-cystathionase inhibitor DL-propargylglycine. The major routes of sulfate formation from L-cysteine therefore seems to involve pathways that do not involve L-cysteinesulfinate. Similar amounts of sulfate were formed from D-cysteine as L-cysteine. Thiosulfate instead of sulfate was also formed in GSH-depleted hepatocytes. However, sulfate formation from D-cysteine differed from L-cysteine in that it was inhibited by the D-aminoacid oxidase inhibitor sodium benzoate and was not affected by transaminase or gamma-cystathionase inhibitors. These results suggest that thiosulfate is an intermediate in sulfate formation from D-cysteine and involves the oxidation of D-cysteine by D-amino acid oxidase to form beta-mercaptopyruvate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609386     DOI: 10.1016/s0009-2797(98)00015-5

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  11 in total

1.  Primary hepatocytes from mice lacking cysteine dioxygenase show increased cysteine concentrations and higher rates of metabolism of cysteine to hydrogen sulfide and thiosulfate.

Authors:  Halina Jurkowska; Heather B Roman; Lawrence L Hirschberger; Kiyoshi Sasakura; Tetsuo Nagano; Kenjiro Hanaoka; Jakub Krijt; Martha H Stipanuk
Journal:  Amino Acids       Date:  2014-03-08       Impact factor: 3.520

2.  Use of Tissue Metabolite Analysis and Enzyme Kinetics To Discriminate between Alternate Pathways for Hydrogen Sulfide Metabolism.

Authors:  Kristie D Cox Augustyn; Michael R Jackson; Marilyn Schuman Jorns
Journal:  Biochemistry       Date:  2017-02-07       Impact factor: 3.162

3.  Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide.

Authors:  Iori Ueki; Heather B Roman; Alessandro Valli; Krista Fieselmann; Jimmy Lam; Rachel Peters; Lawrence L Hirschberger; Martha H Stipanuk
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-06-21       Impact factor: 4.310

Review 4.  Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur.

Authors:  Martha H Stipanuk; Iori Ueki
Journal:  J Inherit Metab Dis       Date:  2010-02-17       Impact factor: 4.982

Review 5.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

6.  Organization of the human mitochondrial hydrogen sulfide oxidation pathway.

Authors:  Marouane Libiad; Pramod Kumar Yadav; Victor Vitvitsky; Michael Martinov; Ruma Banerjee
Journal:  J Biol Chem       Date:  2014-09-15       Impact factor: 5.157

7.  Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.

Authors:  Mariana Brait; Shizhang Ling; Jatin K Nagpal; Xiaofei Chang; Hannah Lui Park; Juna Lee; Jun Okamura; Keishi Yamashita; David Sidransky; Myoung Sook Kim
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

8.  Joint effect of maternal plasma homocysteine and prepregnancy obesity on child blood pressure: a prospective birth cohort study.

Authors:  H Wang; B P Xu; R B Xu; S O Walker; G Wang
Journal:  Int J Obes (Lond)       Date:  2017-05-03       Impact factor: 5.095

9.  Comparisons of l-cysteine and d-cysteine toxicity in 4-week repeated-dose toxicity studies of rats receiving daily oral administration.

Authors:  Yusuke Shibui; Ryosei Sakai; Yasuhiro Manabe; Takeshi Masuyama
Journal:  J Toxicol Pathol       Date:  2017-04-22       Impact factor: 1.628

10.  Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment.

Authors:  Danuta Kowalczyk-Pachel; Małgorzata Iciek; Karolina Wydra; Ewa Nowak; Magdalena Górny; Małgorzata Filip; Lidia Włodek; Elżbieta Lorenc-Koci
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.